The effect of yarrow on menopause

Phase 2

Recruiting

• Registration Number: IRCT20210201050212N1
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 August 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 75

Inclusion Criteria

Be literate
All Women are 65-45
Have at least 3- 20 hot flashes a day
For one year after the last menstrual period

Exclusion Criteria

Absence from two sessions of medical counseling
Have a physical or mental illness
Have a regular exercise program
Taking psychotropic drugs
Have a severely stressful event over the past month
Has taken less than 80% of his medication
Has used soy or phytoestrogens more than once in the past week
Over the past week with a specific illness that is severely stressful or causing pain
During the study, he had to use a special medication that caused sleep disturbances as well as hot flashes
Have changed your sleeping place and place during the last week
Used sleeping pills or hypnotics
He has used psychedelic, sedative and anti-anxiety drugs
Be addicted to drugs such as cigarettes and alcohol
Use medications that cause sleep disturbances or insomnia
History of yarrow or any of its components, people with allergic asthma, seizures, liver disease or cancer
Take any estrogen-based medication to treat menopausal complications (osteoporosis, hot flashes) or other interfering medications such as tibolone with a night shift job.
Menopause due to bilateral removal of the ovaries or undergoing chemotherapy
Treatment for mental disorders or hot flashes in the last 60 days
Hormone Therapy
Use of hormonal contraceptives
Taking selective estrogen receptor modulators or aromatase inhibitors over the past two months
Have severe depression
Have a severe current illness
Suicide attempt in the last 3 weeks
Having bipolar disorder or other mental disorders throughout life
Uncontrolled blood pressure
Taking tamoxifen, raloxifene, antidepressant, clonidine in the last two months

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Flush score. Timepoint: Measure hot flashes before the study and at the end of the first and second months. Method of measurement: Flushing severity questionnaire.